Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Not applicable Interventional

Medical Student Acceptance and Perceptions of Augmented Reality Simulation

ClinicalTrials.gov ID: NCT07947030

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07947030. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Medical Student Acceptance and Perceptions of Augmented Reality Simulation: A Mixed-Methods, Prospective Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This prospective, single-arm, mixed-methods pilot study will evaluate medical students' experiences with, perceptions of, and acceptance of augmented reality (AR) simulation. Medical students completing their core critical care medicine (CCM) clerkship at Stanford University will take part in a single 70-minute augmented reality (AR) simulation session at the Center for Immersive and Simulation-based Learning (CISL). The session includes one instructor-facilitated pediatric intensive care unit (PICU) scenario using an AR headset. The primary outcome is students' experiences and perceptions, explored through thematic analysis of post-simulation focus groups. Secondary outcomes are technology acceptance (Technology Acceptance Model), usability (System Usability Scale), and ergonomics (ISO 9241-400-based questionnaire).

Study identification

NCT ID
NCT07947030
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Stanford University
Other
Enrollment
60 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 15, 2027 (Estimated)
Primary completion
Jan 14, 2028 (Estimated)
Completion
Jan 14, 2028 (Estimated)
Last update posted
Nov 18, 2026

2027 – 2028

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Stanford University Palo Alto California 94305 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07947030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2026 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.